The development of new medicines is a lengthy (typically 12 years), high-risk business since only 1 in 10 000 compounds initially investigated are shown, in three phases of clinical trials, to meet the regulatory requirements of efficacy, quality, and safety.
This may contribute to a therapeutic benefit for MPN patients by allowing the simultaneous satisfaction of the two requirements of efficacy and reduced hematologic adverse effects.
Additionally, Soldiers may have misinterpreted the questions about government regulation of DS, since even without pre-market approval requirements for efficacy and safety, there is some limited de facto regulation by the U.S. government in the form of post-market FDA surveillance.
This standard in instrument development is an increasing regulatory requirement for efficacy evaluation and labeling purposes for treatment interventions [5, 6].
This standard in instrument development is increasingly seen as a regulatory requirement for efficacy evaluation and labeling purposes for treatment interventions [7, 8].
CCOS losing its youth produces an urgent requirement for efficacy and cost-effectiveness to be demonstrated.
However, due to BIO 300's multiple dosing requirement for efficacy, this drug is somewhat less attractive than Ex-RAD (two doses) for development as a general medical countermeasure for ARS.
Note, however, that the time estimated for application of an ABHR was 20 s; considerably shorter than the dry-time for the 3-mL volume required to meet EN 1500 efficacy requirements.
First three required data sets to define design domains are expressed as contour maps in terms of the forward current and the junction temperature (If and Tj): (1) face lumen and cost requirement as lumen/LED; (2) power consumption and energy requirement as luminaire efficacy (LE); and (3) reliability requirement as L70 lifetime.
Of note, Soldiers were more apt to believe the government requires DS to be safe than to think the government imposes strict efficacy requirements, particularly if they used DS.
